Dieter Natlacen

Cabinet decision on the Statutory Health Insurance Contribution Stabilization Act – Financial burdens on German pharmaceutical companies

par Dr. Daniel Tietjen et Ennio Schwind, LL.M. Eur.

Federal Administrative Court on the Delineation between Substance-Based Medical Devices and Medicinal Products

par Daniel Dietrich et Dr. Daniel Tietjen

CJEU Advocate General on Distributors’ Obligations for Medical Devices

par Dr. Daniel Tietjen et Daniel Dietrich

Federal Court of Justice Ruling on Public Advertising for Medical Cannabis on Online Platforms

par plusieurs auteurs

Proposed Amendments to the EU Medical Device Regulation

par Bartosz Świdrak

The 2026 Pharma Package: A New Regulatory Framework for Medicinal Products in the EU

par Irina Rebin

Impact of the new Biotech Act on Clinical Trials in the EU

par Irina Rebin

Life Sciences Legal Lens – Vol. 1

Hungary opens health data infrastructure for AI development

par János Kopasz, AIGP, CIPP/E, CIPM

Promotional activities for medical devices may qualify as agency even without direct negotiation power

par Annabelle Lebaudy